The effect was dose-dependent on NAD+ availability, not NADHgiving patients NADH directly had no effect on sirtuin activation because NADH doesn't bind to the sirtuin active site
Timestamps 00:00 Intro and disclaimers (not a doctor, not a lawyer) 01:40 History: How the Biden FDA scheduled 19 peptides as Category 2 02:44 The rise of the research peptide gray market (4 out of 5 peptides) 04:18 RFK on Joe Rogan and the FDA's Category 1 plans 04:58 What Category 1 actually means (Sermorelin example) 05:42 The July hearing and February 2027 final say timeline 07:18 FDA cracking down on GLP-1s from research companies 08:42 More compounding pharmacies and telehealth clinics entering the space 09:08 The Metformin analogy and future price parity 13:20 The rug pull theory: FDA and Big Pharma quid pro quo on GLP-1s 14:04 Why Eli Lilly is protecting retatrutide (projected $50B/year product) 17:04 Final thoughts and the golden age of peptides Hunter & Taylor Answer Your Most Pressing Health Questions | Reader Mailbag Episode 1 Hunter and Taylor Williams sit down for their first ever Reader Mailbag episode a brand new deep dive Q&A format where they take the questions that need more than 60 seconds and actually break them down together
Companies like United Healthcare, Cigna, and Blue Cross Blue Shield may cover the medication, usually requiring prior authorization
doi: 10.1177/17474930241253988 11
This can be especially beneficial for muscles, tendons, and ligaments, where quicker regeneration and reduced scarring are vital to effective healing
Belmar Pharma Solutions Belmar Pharma Solutions has been compounding personalized hormone therapies since 1985
